Triumph Capital Management Bristol Myers Squibb CO Transaction History
Triumph Capital Management
- $234 Million
- Q1 2024
A detailed history of Triumph Capital Management transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Triumph Capital Management holds 14,161 shares of BMY stock, worth $561,625. This represents 0.33% of its overall portfolio holdings.
Number of Shares
14,161
Previous 13,787
2.71%
Holding current value
$561,625
Previous $707,000
8.49%
% of portfolio
0.33%
Previous 0.31%
Shares
5 transactions
Others Institutions Holding BMY
# of Institutions
2,553Shares Held
1.49BCall Options Held
25.9MPut Options Held
20M-
Vanguard Group Inc Valley Forge, PA186MShares$7.38 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY163MShares$6.45 Billion0.21% of portfolio
-
State Street Corp Boston, MA91.6MShares$3.63 Billion0.23% of portfolio
-
Jpmorgan Chase & CO New York, NY88.8MShares$3.52 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$2.78 Billion0.79% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $84.3B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...